Clinical Trial Update: Hyperpolarized Xenon-129 Magnetic Resonance Imaging in Lung Cancer Patients Receiving Radiation Therapy for Investigating Radiation-response and Toxicity [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial at MD Anderson is evaluating hyperpolarized Xenon-129 MRI to assess radiation response and toxicity in lung cancer patients receiving r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lung Cancer | Phase 1 | Status: RECRUITING